A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease
β Scribed by Voon, V.; Krack, P.; Lang, A. E.; Lozano, A. M.; Dujardin, K.; Schupbach, M.; D'Ambrosia, J.; Thobois, S.; Tamma, F.; Herzog, J.; Speelman, J. D.; Samanta, J.; Kubu, C.; Rossignol, H.; Poon, Y.-Y.; Saint-Cyr, J. A.; Ardouin, C.; Moro, E.
- Book ID
- 126873445
- Publisher
- Oxford University Press
- Year
- 2008
- Tongue
- English
- Weight
- 129 KB
- Volume
- 131
- Category
- Article
- ISSN
- 0006-8950
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Subthalamic nucleus stimulation is emerging as an effective surgical therapy for Parkinson's disease. It is considered to be a safe procedure with little morbidity, the most common complications being intracranial haemorrhage and hardware failure. We report on three cases of depression,
## Abstract ## Background: Deep brain stimulation of the subthalamic nucleus (STNβDBS) is an established treatment for patients with Parkinson's disease (PD). Speech impairment is a frequent side effect of the surgery. This study examined the efficacy of an intensive speech treatment, the Lee Silv
## Abstract We report on a patient with Parkinson's disease (PD) who was moderately improved by stimulation of the subthalamic nucleus (STN) and died 2 years after electrode implantation. After neurosurgery, symptoms that had responded to levodopa treatment preoperatively continued to improve. Post